Lumexa Imaging HoldingsLMRI +14.37%8 Net Margin % is 0.68% as of Mar. 2026. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 59.78% on this metric.
The historical rank and industry rank for Lumexa Imaging Holdings's Net Margin % or its related term are showing as below:
LMRI'
s Net Margin % Range Over the Past 10 Years
Min: -13.06 Med: -9.92 Max: -4.6
Current: -5.18
LMRI's Net Margin % is ranked worse than 59.78% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs LMRI: -5.18
Lumexa Imaging Holdings (NAS:LMRI) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Lumexa Imaging Holdings Net Margin % Related Terms
Lumexa Imaging Holdings Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lumexa Imaging Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a Net Margin % of 0.68% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Lumexa Imaging Holdings and its competitors. According to the industry distribution chart, Lumexa Imaging Holdings ranks #489 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 59.8%.
Is Lumexa Imaging Holdings' Net Margin % too high?
Lumexa Imaging Holdings' current Net Margin % is 0.68%. The Medical Devices & Instruments industry median Net Margin % is 2.06. Lumexa Imaging Holdings' value of 0.68% is 67% below this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #489 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' Net Margin % compare to SSII and CBLL?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #489 out of 818 companies for Net Margin %. This places Lumexa Imaging Holdings in the lower half of its industry. The industry median Net Margin % is 2.06. Lumexa Imaging Holdings' value of 0.68% is 67% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current Net Margin % of 0.68% is 67% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current Net Margin % is 0.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current Net Margin % of 0.68%. The current Net Margin % is 0.68% and 67% below the Medical Devices & Instruments industry median of 2.06. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current Net Margin % is 0.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score
Get the complete analysis for LMRI
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 